Lymphoma is a family of cancers, and the subtype strongly influences what happens next. One person may be offered monitoring, while another needs treatment promptly. Understanding that difference can make information from other people’s experiences less confusing. This guide helps adults in Vancouver and across Canada prepare for conversations with their haematology or oncology team.
Start with the full lymphoma name
The main groups are Hodgkin lymphoma and non-Hodgkin lymphoma, which includes many subtypes. A biopsy of a lymph node or another affected site provides tissue for diagnosis. Blood tests and imaging, often including PET-CT, may help assess the extent of disease. Some people need bone marrow testing or other investigations. Ask for the full pathology diagnosis and which tests are necessary in your case. Canadian Cancer Society: lymphoma diagnosis.
Non-Hodgkin lymphoma: a particular focus of Dr. Lemmo’s practice
Dr. Walter Lemmo, ND, has a particular focus on non-Hodgkin lymphoma within his integrative cancer care practice. A consultation considers your exact lymphoma subtype, current treatment or monitoring plan, medicines and supplements, and concerns such as fatigue, sleep, nutrition and emotional wellbeing. Bring your pathology report and the recommendations of your haematology team so that supportive care can be discussed in context.
Why treatment can look very different
Some slow-growing non-Hodgkin lymphomas can be monitored until treatment is needed. Faster-growing types often require prompt treatment. Depending on subtype and circumstances, options include chemotherapy, targeted therapy, immunotherapy, radiation or stem cell transplant. Non-Hodgkin lymphoma treatment.
Hodgkin lymphoma
Hodgkin lymphoma is commonly treated with chemotherapy or chemoimmunotherapy, sometimes with radiation. Other approaches may be considered for disease that returns or does not respond. Ask your team which plan applies to your subtype and what response would look like. Hodgkin lymphoma treatment.
Supporting energy and daily life
Fatigue can have several contributors, including anaemia, sleep difficulties, nutrition problems or emotional distress. Assessment matters because different causes need different management. Low white blood cell counts can also increase infection risk. Ask for clear instructions about temperature checks, symptoms to report and how to reach the treatment team. Supportive care guidance.
An integrative discussion should focus on a defined concern rather than a general promise to “boost immunity.” Ask for evidence relevant to your treatment and current blood counts. Review supplements with your oncology pharmacist before use because they can interact with treatment. BC Cancer guidance.
What to bring and ask
Bring the pathology report, staging results, recent blood tests, treatment schedule and a list of medicines and supplements. Note how fatigue affects your day and any difficulty with food, sleep or practical responsibilities.
- What is the exact subtype, and is it considered slow-growing or aggressive?
- Why is treatment or monitoring appropriate now?
- What is the plan for preventing and responding to infection?
- What side effects or longer-term effects should we discuss before treatment?
- Who will check that supportive therapies fit the haematology plan?
Common questions
Is monitoring a slow-growing lymphoma unsafe?
Monitoring can be a recommended strategy for selected indolent lymphomas. It requires follow-up and clear guidance about changes to report. It should be a decision made with the specialist, not a reason to skip assessment. Monitoring and treatment decisions.
Should fatigue simply be pushed through?
Persistent or changing fatigue deserves assessment. Your team can look for treatable contributors and help plan manageable activity and rest. Report how fatigue affects you rather than assuming it has only one cause. Understanding lymphoma-related fatigue.
This page provides general education. Your lymphoma subtype and medical condition determine the care you need.